Davita Inc (NYSE:DVA) Shares Bought by Meadow Creek Investment Management LLC

Meadow Creek Investment Management LLC increased its stake in Davita Inc (NYSE:DVA) by 3.3% in the 2nd quarter, Holdings Channel.com reports. The fund owned 88,416 shares of the company’s stock after acquiring an additional 2,848 shares during the quarter. Meadow Creek Investment Management LLC’s holdings in Davita were worth $4,974,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of DVA. Oregon Public Employees Retirement Fund boosted its holdings in Davita by 0.5% in the 1st quarter. Oregon Public Employees Retirement Fund now owns 36,727 shares of the company’s stock worth $1,994,000 after buying an additional 185 shares during the last quarter. Oppenheimer & Co. Inc. boosted its stake in shares of Davita by 1.6% in the second quarter. Oppenheimer & Co. Inc. now owns 12,600 shares of the company’s stock worth $709,000 after acquiring an additional 201 shares during the last quarter. Piedmont Investment Advisors Inc. increased its position in shares of Davita by 3.3% during the first quarter. Piedmont Investment Advisors Inc. now owns 6,974 shares of the company’s stock worth $379,000 after purchasing an additional 225 shares in the last quarter. Creative Planning increased its position in shares of Davita by 3.6% during the second quarter. Creative Planning now owns 7,231 shares of the company’s stock worth $407,000 after purchasing an additional 250 shares in the last quarter. Finally, Commonwealth Equity Services LLC raised its stake in Davita by 2.3% in the 2nd quarter. Commonwealth Equity Services LLC now owns 11,337 shares of the company’s stock valued at $637,000 after purchasing an additional 251 shares during the last quarter. Institutional investors own 91.47% of the company’s stock.

Shares of NYSE:DVA traded down $2.25 during midday trading on Wednesday, hitting $59.41. The company had a trading volume of 870,369 shares, compared to its average volume of 4,047,611. Davita Inc has a twelve month low of $43.40 and a twelve month high of $79.11. The stock has a market cap of $9.63 billion, a price-to-earnings ratio of 16.64, a price-to-earnings-growth ratio of 0.58 and a beta of 1.59. The company has a debt-to-equity ratio of 1.90, a current ratio of 1.12 and a quick ratio of 1.10. The business’s 50-day simple moving average is $58.24 and its 200-day simple moving average is $54.36.



Davita (NYSE:DVA) last released its quarterly earnings data on Thursday, August 1st. The company reported $1.22 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.10 by $0.12. The company had revenue of $2.84 billion for the quarter, compared to analyst estimates of $2.86 billion. Davita had a return on equity of 14.67% and a net margin of 1.21%. The firm’s revenue for the quarter was down 1.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.05 earnings per share. As a group, sell-side analysts forecast that Davita Inc will post 4.79 EPS for the current year.

A number of research analysts have weighed in on the company. SunTrust Banks restated a “hold” rating and issued a $68.00 price objective on shares of Davita in a report on Wednesday. UBS Group dropped their target price on shares of Davita from $61.00 to $60.00 and set a “neutral” rating for the company in a report on Thursday, August 22nd. TheStreet raised shares of Davita from a “c+” rating to a “b-” rating in a report on Wednesday, July 24th. Robert W. Baird cut shares of Davita from an “outperform” rating to a “neutral” rating and reduced their target price for the company from $70.00 to $65.00 in a research report on Friday, July 26th. Finally, William Blair downgraded shares of Davita from an “outperform” rating to a “market perform” rating in a research note on Wednesday. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and two have assigned a buy rating to the stock. Davita currently has an average rating of “Hold” and a consensus target price of $67.31.

About Davita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Featured Article: Why do analysts give a neutral rating?

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).

Institutional Ownership by Quarter for Davita (NYSE:DVA)

Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.